| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/05/2006 | EP1675652A2 Treatment of ocular disease |
| 07/05/2006 | EP1418881A4 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 07/05/2006 | EP1234582B1 Concomitant drugs for treating glaucoma |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | CN1798576A Drug for preventing or treating angiogenic eye diseases |
| 07/05/2006 | CN1262556C Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
| 07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071225 Arylaminopropane analogues and their use for the treatment of glaucoma |
| 07/04/2006 | US7071221 Heterocyclic oxime compounds |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071170 Bactericides; antiprotozoa agents |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | CA2404848C Indole carboxylic acids as thyroid receptor ligands |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 06/29/2006 | WO2006068899A2 Preserved ophthalmic compositions comprising aloe vera |
| 06/29/2006 | WO2006068829A1 Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (lox) and lox-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| 06/29/2006 | WO2006068795A2 Use of inhibitors of formyl peptide receptors for reducing intraocular pressure |
| 06/29/2006 | WO2006068266A1 PROSTAGLANDIN F2α DERIVATIVE CONTAINING PRODUCTS |
| 06/29/2006 | WO2006068208A1 Preventive or therapeutic agent for glaucoma |
| 06/29/2006 | WO2006068199A1 Metabolically stable 3-oxy-1,2,4-triazole derivatives |
| 06/29/2006 | WO2006068105A1 Therapeutic agent for keratoconjunctive disorder |
| 06/29/2006 | WO2006067330A1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 06/29/2006 | WO2006066987A1 Anti-radical agents |
| 06/29/2006 | WO2006066846A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 06/29/2006 | WO2006066780A1 Combinations of valategrast and montelukast for treating asthma |
| 06/29/2006 | WO2006066511A1 Diazene-bridged crown ether lithium compounds and methods for their use |
| 06/29/2006 | WO2006028269A3 Thiazole derivatives having vap-1 ihibitory activity |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142249 Ophthalmic use |
| 06/29/2006 | US20060142169 Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | CA2592474A1 Prostaglandin f2.alpha. derivative-containing product |
| 06/29/2006 | CA2592004A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 06/29/2006 | CA2585372A1 Preventive or therapeutic agent for glaucoma |
| 06/28/2006 | EP1674456A2 Substituted alpha-halo-beta-keto-pyridinylpropanoates |
| 06/28/2006 | EP1674100A1 Angiogenesis inhibitor |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674091A1 Ophthalmic composition for treating lacrimal disorders |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | CN1795196A Agent for repairing corneal sensitivity containing amide compound |
| 06/28/2006 | CN1795008A Histamine binding compounds for treatment method for disease conditions mediated by neutrophils. |
| 06/28/2006 | CN1794988A Method for treating vascular hyperpermeable disease |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261115C Chinese traditional medicine preparation for treating diabetic chronic retinopathy and preparation method thereof |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives |
| 06/27/2006 | US7067520 Antidiabetic agents; hypoglycemic agents; antilipemic agents; dietetics |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067493 Single dose azithromycin |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006065916A1 Method of treating dry eye disorders using 13(s)-hode and its analogs |
| 06/22/2006 | WO2006064825A1 Therapeutic agent for dry eye |
| 06/22/2006 | WO2006064672A1 Therapeutic agent for ophthalmic diseases |
| 06/22/2006 | WO2006064281A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 06/22/2006 | WO2006063585A1 Triazole substituted aminobenzophenone compounds |
| 06/22/2006 | WO2003061655A8 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135611 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060134088 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition therefor in form of a kit |
| 06/22/2006 | US20060133994 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 06/22/2006 | CA2590479A1 Triazole substituted aminobenzophenone compounds |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1670465A1 Ocular solutions containing a macrolide antibiotic and/or mycophenolic acid |
| 06/21/2006 | EP1545590B1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 06/21/2006 | EP1506193B1 Carbamate-substituted pyrazolopyridines |
| 06/21/2006 | EP1448753B1 Conditioning solution for contact lenses |